Isoquinoline

Isoquinoline

SCHEMBL7076555

c1ccc2cnccc2c1.c1ccc2nnccc2c1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.39
CLK1 P49759 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
AR P10275 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 3/20 0.37
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
TNF P01375 1/20 0.37
POLB P06746 1/20 0.37
HTT P42858 1/20 0.37
RAD52 P43351 1/20 0.37
MAPT P10636 3/20 0.37
GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoquinoline SCHEMBL6529066 0.92 ALDH1A1 (0.55) EGFRCLK1CYP1A2CYP3A4CYP2D6
Naphthalene SCHEMBL28320375 0.88 ALDH1A1 (0.41) EGFRCYP1A2CYP3A4CYP2D6CYP2C9
Phthalazine SCHEMBL28873248 0.86 ALDH1A1 (0.43) EGFRCYP1A2CYP3A4CYP2D6CYP2C9
Phthalazine SCHEMBL4646099 0.86 ALDH1A1 (0.43) EGFRCYP1A2CYP3A4CYP2D6CYP2C9
Cinnoline SCHEMBL8197 0.85 ALDH1A1 (0.50) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Cinnoline SCHEMBL29367576 0.85 ALDH1A1 (0.50) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Isoquinoline SCHEMBL1533865 0.85 EGFR (0.56) EGFRCLK1CYP3A4NPC1RAB9A
Cinnoline SCHEMBL29184286 0.83 ALDH1A1 (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Cinnoline SCHEMBL29388384 0.83 ALDH1A1 (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Cinnoline SCHEMBL8589764 0.83 ALDH1A1 (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5243004-A Polymeric conductors FUJI PHOTO FILM CO., LTD. (JP) 1993-09-07 US claimed
US-20030207863-A1 Preventives and remedies for central nervous system diseases TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-11-06 US disclosed
EP-1331010-A1 PREVENTIVES AND REMEDIES FOR CENTRAL NERVOUS SYSTEM DISEASES Takeda Chemical Industries, Ltd. (JP) 2003-07-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207863-A1 Preventives and remedies for central nervous system diseases UTS2R, PRSS12, CTSA EGFR 2283/4885CLK1 3008/4885CYP1A2 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.